TypeSafe AI
Developer infrastructure that turns unstructured inputs into typed decisions and probability scores for automated software workflows.
$40MSeed
LeadD
DCVC
Activity from announced rounds
Activity in this selectioncoalition-operators-a795461a
- Rounds participated in
- 2
- Confirmed lead rounds
- 1 All roles disclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $52M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionShennon Biotechnologies
Shennon Biotechnologies is developing precision T-cell engager immunotherapies for solid tumors.
$12MFunding
Participant